Cellular modifications in spermatogenesis during seasonal testicular regression: an update review in mammals
No published study has shown BPC-157 causes cancer in humans or animals, and some preclinical work even suggests anti-tumor activity in certain models, but the mechanism means caution is warranted rather than dismissed
Benefits: Low-Level Light Therapy (LLLT) clinically benefits patients by enhancing the health and comfort of the eyes and eyelids through the following mechanisms: Stimulating anti-inflammatory pathways, thereby reducing ocular and eyelid inflammation Enhancing microvascular perfusion and increasing circulation, which helps clear inflammatory mediators and improve tissue oxygenation Reducing bacterial biofilm Enhancing Meibomian gland repair and regeneration Helping to unblock Meibomian glands by melting and mobilizing meibum, thereby improving gland function, restoring oil flow to the tear film, increasing tear film stability, and decreasing tear evaporation from the ocular surfacemaking the eyes less dry and more comfortable Stimulating lacrimal and Meibomian gland activity Reducing telangiectasia and improving vascular tone, thereby mitigating flare-ups In our practice, we use a professional medical-grade LLLT device* that provides the flexibility needed to customize treatments based on each patients individual needs (such as skin type and the condition being treated)
Patients often develop severe facial edema that is central with periorbital sparing
World Applied Sciences Journal , 31 (11), 19111916
Protocol emphasis: BPC-157 for vascular protection (200-500mcg daily), GHK-Cu for oxidative stress (1-2mg 3x weekly), Carnosine for glycation protection (1g daily supplement), Strict injection site rotation and hygiene preventing infections
